Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Vivesto AB ADR News

    0,02 $ 0,00% +0,00 $
    In : 0,0187 € | 19.03.24 17:15:59 Nasdaq OTC Other aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A2JNBP
    ISIN: US67421W1099
    US-Symbol: OASMY
    Typ: Aktie

    Vivesto AB ADR News

    18.09.19 - PR Newswire
    DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Oasmia Pharmaceutical AB (NASDAQ: OASM) and Encourages Oasmia Investors to Contact the Firm
    DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Oasmia Pharmaceutical AB (NASDAQ: OASM) and ...
    01.08.19 - PR Newswire
    SHAREHOLDER ALERT - Oasmia Pharmaceutical AB (OASM) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Plaintiff Deadline: September 27, 2019
    SHAREHOLDER ALERT - Oasmia Pharmaceutical AB (OASM) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Plaintiff Deadline: September 27, ...
    31.07.19 - PR Newswire
    LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Oasmia Pharmaceutical AB To Contact The Firm
    LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Oasmia Pharmaceutical AB To Contact The Firm PR ...
    29.07.19 - PR Newswire
    EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Oasmia Pharmaceutical AB - OASM
    EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Oasmia Pharmaceutical AB - OASM PR Newswire
    26.07.19 - PR Newswire
    Lifshitz & Miller LLP Announces Investigation of Caesars Entertainment Corporation, Del Frisco's Restaurant Group, Inc., Diebold Nixdorf, Inc., FedEx Corporation, Oasmia Pharmaceuticals, Shore Community Bancorp, Verb Technology Company and WageWorks, Inc.
    Lifshitz & Miller LLP Announces Investigation of Caesars Entertainment Corporation, Del Frisco's Restaurant Group, Inc., Diebold Nixdorf, Inc., FedEx Corporation, Oasmia ...
    10.10.18 - PR Newswire
    Thinking about buying stock in Ford, Fastenal, Oasmia Pharmaceutical, One Horizon Group or Zynga?
    Thinking about buying stock in Ford, Fastenal, Oasmia Pharmaceutical, One Horizon Group or Zynga? PR Newswire
    27.04.16 - PR Newswire
    Oasmia Pharmaceutical verkündet positive allgemeine Überlebensergebnisse von der Phase-III-Studie mit Apealea/Paclical für die Behandlung von Eierstockkrebs
    Oasmia Pharmaceutical verkündet positive allgemeine Überlebensergebnisse von der Phase-​III-Studie mit Apealea/Paclical für die Behandlung von Eierstockkrebs PR Newswire
    27.04.16 - PR Newswire
    Oasmia Pharmaceutical Announces Positive Overall Survival Results From Phase III Study of Apealea/Paclical for Treatment of Ovarian Cancer
    Oasmia Pharmaceutical Announces Positive Overall Survival Results From Phase III Study of Apealea/Paclical for Treatment of Ovarian Cancer Overall Survival data from the Phase ...
    27.04.16 - PR Newswire
    Oasmia Pharmaceutical Announces Positive Overall Survival Results From Phase III Study of Apealea/Paclical for Treatment of Ovarian Cancer
    Oasmia Pharmaceutical Announces Positive Overall Survival Results From Phase III Study of Apealea/Paclical for Treatment of Ovarian Cancer PR Newswire
    08.02.16 - PR Newswire
    Oasmia beantragt Marktzulassung seines führenden Krebsproduktes Apealea® (Paclical®) bei der Europäischen Arzneimittel-Agentur
    Oasmia beantragt Marktzulassung seines führenden Krebsproduktes Apealea® (Paclical®) bei der Europäischen Arzneimittel-​Agentur PR Newswire
    08.02.16 - PR Newswire
    Oasmia Has Submitted a Marketing Authorization Application to the European Medicines Agency for Its Lead Cancer Product Apealea® (Paclical®)
    Oasmia Has Submitted a Marketing Authorization Application to the European Medicines Agency for Its Lead Cancer Product Apealea® (Paclical®) Oasmia Pharmaceutical AB ...
    08.02.16 - PR Newswire
    Oasmia Has Submitted a Marketing Authorization Application to the European Medicines Agency for Its Lead Cancer Product Apealea® (Paclical®)
    Oasmia Has Submitted a Marketing Authorization Application to the European Medicines Agency for Its Lead Cancer Product Apealea® (Paclical®) PR Newswire

    Newssuche

    Videos

    newspaper
    24.04.24
    Technical Trading: AUD/USD mit Mega Chance
    AUD/USD Long Typ: Turbo Open End WKN: UM0EHU Hebel: 6,42 Laufzeit: OpenEnd Einstieg: Market ... Mehr »